Ceftriaxone Sodium
24 NDCs across 3 manufacturers|24 Generic,0 Brand
Ceftriaxone Sodium is used to treat acinetobacter infections, bacteroidaceae infections, infectious bone diseases, chancroid, clostridium infections and enteritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 21, 1984, and the first generic was approved Mar 12, 1985. In 2024, Medicare Part D spent $22 million on Ceftriaxone Sodium across 354,000 claims for 158,000 beneficiaries.
Ceftriaxone Sodium is available as 24 NDCs from 3 manufacturers (24 generic, 0 brand), with NADAC prices from $0.86 to $25.21 per EA — the most expensive product costs about 29× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
24
24G / 0B
Manufacturers
3
competing in market
Price Spread
$0.86 – $25.21
per EA
7d Activity
avg +1.2% WoW · of 24 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
3 manufacturers producing CEFTRIAXONE SODIUM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CEFTRIAXONE 10 GM VIAL | $25.2133 per EA | — |
CEFTRIAXONE 10 GM VIAL | $25.2133 per EA | — |
CEFTRIAXONE 1 GM VIAL | $3.4500 per EA | — |
CEFTRIAXONE 1 GM VIAL | $3.4500 per EA | — |
CEFTRIAXONE 2 GM VIAL | $2.7000 per EA | +1.70% |
CEFTRIAXONE 2 GM VIAL | $2.7000 per EA | +1.70% |
CEFTRIAXONE 2 GM VIAL | $2.7000 per EA | +1.70% |
CEFTRIAXONE 2 GM VIAL | $2.7000 per EA | +1.70% |
CEFTRIAXONE 500 MG VIAL | $1.8076 per EA | +1.21% |
CEFTRIAXONE 500 MG VIAL | $1.8076 per EA | +1.21% |
CEFTRIAXONE 500 MG VIAL | $1.2976 per EA | +4.31% |
CEFTRIAXONE 500 MG VIAL | $1.2976 per EA | +4.31% |
CEFTRIAXONE 500 MG VIAL | $1.2976 per EA | +4.31% |
CEFTRIAXONE 500 MG VIAL | $1.2976 per EA | +4.31% |
CEFTRIAXONE 250 MG VIAL | $1.2533 per EA | — |
CEFTRIAXONE 250 MG VIAL | $1.2533 per EA | — |
CEFTRIAXONE 1 GM VIAL | $1.1954 per EA | -2.47% |
CEFTRIAXONE 1 GM VIAL | $1.1954 per EA | -2.47% |
CEFTRIAXONE 1 GM VIAL | $1.1954 per EA | -2.47% |
CEFTRIAXONE 1 GM VIAL | $1.1954 per EA | -2.47% |
CEFTRIAXONE 250 MG VIAL | $0.8622 per EA | — |
CEFTRIAXONE 250 MG VIAL | $0.8622 per EA | — |
CEFTRIAXONE 250 MG VIAL | $0.8622 per EA | — |
CEFTRIAXONE 250 MG VIAL | $0.8622 per EA | — |
Frequently Asked Questions
What is Ceftriaxone Sodium used to treat?
Ceftriaxone Sodium is used to treat acinetobacter infections, bacteroidaceae infections, infectious bone diseases, chancroid, clostridium infections and enteritis, per the National Library of Medicine's MED-RT classification.
When did Ceftriaxone Sodium become available as a generic?
FDA approved the first generic Ceftriaxone Sodium (ANDA) on Mar 12, 1985.
How much does Medicare spend on Ceftriaxone Sodium?
In 2024, Medicare Part D spent $22 million on Ceftriaxone Sodium across 354,000 claims for 158,000 beneficiaries.
How many Ceftriaxone Sodium products are on the market?
The Ceftriaxone Sodium drug market contains 24 NDCs from 3 manufacturers — 24 generic and 0 brand products.
What is the price range for Ceftriaxone Sodium?
NADAC reference prices for Ceftriaxone Sodium range from $0.8622 to $25.2133 per EA — the most expensive product costs about 29× the cheapest.
Which manufacturers make Ceftriaxone Sodium?
3 manufacturers list Ceftriaxone Sodium in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (9), Sandoz Inc. (8), Apotex Corp. (7).
How has the price of Ceftriaxone Sodium changed recently?
Over the past 7 days, 10 Ceftriaxone Sodium NDCs rose and 4 fell, with a market-wide average change of +1.2%.